About Dr. Sirisha Rani
Dr. Sirisha Rani is a distinguished Senior Consultant in Paediatric Hematology-Oncology and Bone Marrow Transplantation based in Hyderabad. She is recognised as one of the top Paediatric Oncologist in India. Dr. Rani’s expertise encompasses the comprehensive management of childhood cancers, including leukaemias and lymphomas, complex blood disorders, and performing intricate bone marrow transplants. She earned her MD in Paediatrics from the prestigious PGIMER, Chandigarh, where she was lauded as the best outgoing student. Her advanced training includes a fellowship in Paediatric Hematology-Oncology and BMT from esteemed institutions in the United Kingdom, such as Great Ormond Street Hospital. Dr. Rani is deeply committed to advancing paediatric cancer care through clinical excellence, research, and training future specialists.
- MBBS: Dr. NTR University of Health Sciences, Andhra Pradesh
- MD (Paediatrics): Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh
- DNB (Paediatrics): National Board of Examinations, New Delhi
- Fellowship in Paediatric Hematology-Oncology and BMT (UK)
- Training: Great Ormond Street Hospital, London, UK
- Training: Bristol Children’s Hospital, Bristol, UK
- Training: Cardiff University Hospital, Cardiff, UK
- MRCPCH (UK): Member of the Royal College of Paediatrics and Child Health, UK
- Registered with Andhra Pradesh Medical Council (Reg. No: 40525, Year: 1997)
- Acute Lymphoblastic Leukaemia (ALL)
- Acute Myeloid Leukaemia (AML)
- Lymphomas (Hodgkin and Non-Hodgkin)
- Neuroblastoma
- Wilms’ Tumor (Kidney Cancer)
- Brain Tumors
- Sarcomas (Bone and Soft Tissue)
- Langerhans Cell Histiocytosis (LCH)
- Hepatoblastoma (Liver Cancer)
- Other solid tumors in children tumor
- Paediatric Hematology (Anaemias, Thalassemia, Sickle Cell Disease, ITP, Bleeding Disorders)
- Paediatric Oncology (Childhood Cancers)
- Bone Marrow Transplantation (Autologous and Allogeneic)
- Management of Acquired Aplastic Anaemia
- Bone Marrow Transplantation
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Senior Consultant – Paediatric Hematology-Oncology and BMT, Rainbow Children’s Hospital, Banjara Hills, Hyderabad (Since Feb 2019) (Current)
- Paediatric Oncologist, Great Ormond Street Hospital, London
- Paediatric Oncologist, Bristol Children’s Hospital, Bristol
- Paediatric Oncologist, Cardiff University
- Senior Resident, St Johns Hospital, Bangalore
- Senior Resident, Kidwai Memorial Cancer Institute, Bangalore
- Lecturer in Paediatrics, St John’s Medical College and Hospital, Bangalore
- Accredited FNB training programme guide in Paediatric Hematology-Oncology at Rainbow Children’s Hospital.
- Regularly conducts PG training programs and CMEs in Paediatric Hematology & Oncology.
- Central India executive member of the National Paediatric Hematology-Oncology (PHO) society.
- Zonal coordinator for PHO training programmes.
- Conducted the Midterm National conference of PHO (July 2016).
- Instrumental in Rainbow Children’s Hospital (Dept. of Paediatric Hematology-Oncology) receiving accreditation for the FNB training programme.
- Significant contributions to research with national and international publications and presentations at forums like SIOP, PHOCON, and St Jude Viva Forum.
- Recognised for expertise in treating a complete spectrum of paediatric oncology and hematology cases.
- Best Outgoing Student – MD (Paediatrics), PGIMER, Chandigarh
- Recognition for presentations at international forums like SIOP.
- Immunodeficiency, motor delay, and hypouricemia caused by a novel mutation of purine nucleoside phosphorylase gene in an Indian infant. Annals of Indian Academy of Neurology. (2019).
- Diagnosis and management of acquired aplastic anemia: Consensus statement of Indian Academy of Pediatrics. Indian pediatrics. (2022).
- High dose chemotherapy with autologous stem cell rescue for pediatric high risk brain tumours -Case series. Pediatric Hematology Oncology Journal. (2023).
- Impact of minimal residual disease on predicting outcomes in pediatric acute lymphoblastic leukemia; An Indian tertiary care centre study. Pediatric Hematology Oncology Journal. (2023).
- Neuroblastoma with opsoclonus myoclonus ataxia syndrome – Case series from tertiary care center. Pediatric Hematology Oncology Journal. (2023).
- Outcome of hepatoblastoma – A single centre experience. Pediatric Hematology Oncology Journal. (2023).
- Hematopoietic stem cell transplant in rare metabolic disorders: Case series from tertiary care centre. Pediatric Hematology Oncology Journal. (2023).
- Salvage therapy with cladribine and cytarabine in refractory multisystem langerhans cell histiocytosis – A single centre experience. Pediatric Hematology Oncology Journal. (2021).
Treatment/Condition | Estimated Cost Range (INR) | Estimated Cost Range (USD) |
Paediatric Leukaemia (ALL/AML) – Chemotherapy & Supportive Care | ₹8,00,000 – ₹25,00,000+ | $9,600 – $30,000+ |
Paediatric Lymphoma – Treatment | ₹7,00,000 – ₹20,00,000+ | $8,400 – $24,000+ |
Paediatric Solid Tumors (e.g., Neuroblastoma, Wilms’ Tumor) – Multimodal Treatment | ₹5,00,000 – ₹20,00,000+ | $6,000 – $24,000+ |
Autologous Bone Marrow Transplant | ₹10,00,000 – ₹20,00,000 | $12,000 – $24,000 |
Allogeneic Bone Marrow Transplant (Related Donor) | ₹18,00,000 – ₹35,00,000 | $21,600 – $42,000 |
Allogeneic Bone Marrow Transplant (MUD/Unrelated Donor) | ₹25,00,000 – ₹50,00,000+ | $30,000 – $60,000+ |
- Language Support: Assistance with English, Telugu, and Hindi. Arrangements for other language interpreters can be made upon request.
- Visa & Travel Assistance: Guidance and support for visa applications, travel arrangements, airport transfers, and accommodation booking.
- Pre-treatment Virtual Consultations: Facilitation of pre-treatment online consultations with Dr. Sirisha Rani to discuss medical reports and treatment plans before travelling.